Capital Research Global Investors’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-11,580,091
Closed -$1.1B 452
2018
Q3
$1.1B Sell
11,580,091
-1,868,644
-14% -$159M 0.32% 67
2018
Q2
$1.04B Sell
13,448,735
-3,646,276
-21% -$274M 0.28% 83
2018
Q1
$1.18B Sell
17,095,011
-1,965,880
-10% -$150M 0.34% 73
2017
Q4
$1.42B Buy
19,060,891
+5,639,990
+42% +$361M 0.42% 64
2017
Q3
$850M Sell
13,420,901
-432,156
-3% -$26.9M 0.26% 101
2017
Q2
$884M Sell
13,853,057
-125,378
-0.9% -$7.87M 0.28% 95
2017
Q1
$921M Sell
13,978,435
-584,274
-4% -$40.2M 0.29% 94
2016
Q4
$1B Buy
14,562,709
+3,012,972
+26% +$216M 0.32% 78
2016
Q3
$815M Sell
11,549,737
-674,315
-6% -$50.4M 0.27% 97
2016
Q2
$927M Buy
12,224,052
+9,812
+0.1% +$721K 0.32% 83
2016
Q1
$839M Sell
12,214,240
-1,743,569
-12% -$125M 0.29% 93
2015
Q4
$1.22B Buy
13,957,809
+15,000
+0.1% +$1.28M 0.42% 61
2015
Q3
$1.13B Buy
13,942,809
+4,725,000
+51% +$412M 0.4% 64
2015
Q2
$820M Buy
9,217,809
+4,148,326
+82% +$362M 0.27% 93
2015
Q1
$440M Hold
5,069,483
0.15% 143
2014
Q4
$429M Buy
+5,069,483
New +$396M 0.15% 152
2014
Q2
Sell
-10,891,401
Closed -$818M 455
2014
Q1
$818M Buy
10,891,401
+1,412,601
+15% +$106M 0.3% 99
2013
Q4
$666M Buy
9,478,800
+693,800
+8% +$45.3M 0.25% 112
2013
Q3
$543M Buy
8,785,000
+2,978,000
+51% +$193M 0.21% 118
2013
Q2
$358M Buy
+5,807,000
New +$350M 0.15% 144

Other funds holding ESRX

Capital Research Global Investors's ESRX Position: Q4 2018 in Review

Capital Research Global Investors sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 11,580,091 shares — an estimated $1.1B sold.

Capital Research Global Investors first reported a position in ESRX in Q2 2013 and held it in 20 quarters. The position peaked at $1.42B in Q4 2017. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.

  • Capital Research Global Investors reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
  • Capital Research Global Investors sold 11,580,091 Express Scripts Holding Company shares in Q4 2018, an estimated $1.1B.
  • Capital Research Global Investors first reported a position in Express Scripts Holding Company in Q2 2013 and held it in 20 quarters.
  • Capital Research Global Investors's Express Scripts Holding Company position peaked at $1.42B in Q4 2017.
  • 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.

Based on Capital Research Global Investors's 13F filing for Q4 2018, filed 14 Feb 2019.